CYP3A5 Polymorphism in Circulating Tumor Cells Confers an Increased Disease-Free Survival in DLBCL Patients Treated with R-CHOP

Cerón Maldonado R, Martínez Tovar A, Ramos Peñafiel CO, De la Cruz Rosas A, García Laguna AI, Mendoza Salas I, Martínez Murillo C, Barranco Lampón GI, Montaño Figueroa EH, Jiménez-Morales S, Olarte Carrillo I

OncoTargets and Therapy 2025, 18:355-366

Published Date: 14 March 2025